Salud financiera de hoja de balance de AstraZeneca Pharma India
Salud financiera controles de criterios 6/6
AstraZeneca Pharma India tiene un patrimonio de accionistas total de ₹7.1B y una deuda total de ₹0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son ₹10.8B y ₹3.7B respectivamente. El BAIT de AstraZeneca Pharma India es de ₹1.7B, por lo que su ratio de cobertura de intereses es de 141.2. Tiene efectivo e inversiones a corto plazo que ascienden a ₹5.1B.
Información clave
0%
Ratio deuda-patrimonio
₹0
Deuda
| Ratio de cobertura de intereses | -5.5x |
| Efectivo | ₹5.06b |
| Patrimonio | ₹7.12b |
| Total pasivo | ₹3.66b |
| Activos totales | ₹10.78b |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
We Believe AstraZeneca Pharma India's (NSE:ASTRAZEN) Earnings Are A Poor Guide For Its Profitability
Jun 03
Why Investors Shouldn't Be Surprised By AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) P/S
May 22We Ran A Stock Scan For Earnings Growth And AstraZeneca Pharma India (NSE:ASTRAZEN) Passed With Ease
Apr 04Is Now The Time To Put AstraZeneca Pharma India (NSE:ASTRAZEN) On Your Watchlist?
Nov 10AstraZeneca Pharma India's (NSE:ASTRAZEN) Dividend Will Be Increased To ₹16.00
Jul 06Is Now The Time To Put AstraZeneca Pharma India (NSE:ASTRAZEN) On Your Watchlist?
Jun 16Increases to CEO Compensation Might Be Put On Hold For Now at AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
Aug 02Here's Why I Think AstraZeneca Pharma India (NSE:ASTRAZEN) Is An Interesting Stock
Feb 25Could The AstraZeneca Pharma India Limited (NSE:ASTRAZEN) Ownership Structure Tell Us Something Useful?
Feb 04Declining Stock and Solid Fundamentals: Is The Market Wrong About AstraZeneca Pharma India Limited (NSE:ASTRAZEN)?
Jan 18
Announcing: AstraZeneca Pharma India (NSE:ASTRAZEN) Stock Increased An Energizing 282% In The Last Five Years
Dec 31We're Not Counting On AstraZeneca Pharma India (NSE:ASTRAZEN) To Sustain Its Statutory Profitability
Dec 13Here's Why We Think AstraZeneca Pharma India (NSE:ASTRAZEN) Is Well Worth Watching
Nov 25Here's What We Think About AstraZeneca Pharma India's (NSE:ASTRAZEN) CEO Pay
Nov 07What Kind Of Investors Own Most Of AstraZeneca Pharma India Limited (NSE:ASTRAZEN)?
Oct 20AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Sep 24If You Had Bought AstraZeneca Pharma India (NSE:ASTRAZEN) Stock Three Years Ago, You Could Pocket A 298% Gain Today
Aug 28What Did AstraZeneca Pharma India's (NSE:ASTRAZEN) CEO Take Home Last Year?
Aug 02Could The AstraZeneca Pharma India Limited (NSE:ASTRAZEN) Ownership Structure Tell Us Something Useful?
Jul 12Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹9.3B) de ASTRAZEN superan a sus pasivos a corto plazo (₹3.6B).
Pasivo a largo plazo: Los activos a corto plazo de ASTRAZEN (₹9.3B) superan a sus pasivos a largo plazo (₹89.9M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: ASTRAZEN está libre de deudas.
Reducción de la deuda: ASTRAZEN no tenía deudas hace 5 años.
Cobertura de la deuda: ASTRAZEN no tiene deuda, por lo tanto no necesita estar cubierta por flujo de caja operativo.
Cobertura de intereses: ASTRAZEN no tiene deuda, por lo que la cobertura de pagos de intereses no es motivo de preocupación.